35 Burst results for "Biotech Company"

Wildfires Can Contaminate Outdoor Marijuana Crops

Climate Connections

01:11 min | Last month

Wildfires Can Contaminate Outdoor Marijuana Crops

"As more states. Pass laws permitting. Marijuana use the legal barriers to growing cannabis are crumbling but wildfires. Pose risks to many outdoor growers in california and the pacific northwest. Jonathan vodka is ceo of front range biosciences a colorado based biotech company that breeds hemp and provides nursery expertise to cannabis growers. He says wildfire smoke in temporarily block out sunlight that can shorten the time. The plant spends growing branches and leaves. It can stunt the growth it can even with a photosensitive plant like cannabis closet it to go into early. Flowering that can reduce the overall yield soot. An ash can also settle onto leaves and soil. Some of it can be cleaned off but much is still unknown about how wildfire smoke can affect the plants in the longer term fought says smoke could taint the flavor or even worse if buildings or structures that contain lead or fire retardants burn than you can actually ended up with even much more toxic types of compounds that can contaminate your crop as the climate changes. Wildfires are getting more extreme law. Gore's ac new opportunities as canada's laws change they may also face growing

Jonathan Vodka Front Range Biosciences Pacific Northwest Colorado California Gore Canada
Has the Reddit brigade found a new target?

CNBC's Fast Money

02:01 min | 3 months ago

Has the Reddit brigade found a new target?

"Wines. Have the read it. Traders found a new target guidance. This is certainly an interesting space to target. It is very complicated. it is very technical. And in many instances not very liquid. And it's very binary and there are a number of these names that have huge short interests as to add so it's oil it's all of those are sort of the all the things that i think people on this platform the read it platform would be looking for then. You mentioned cassava so quickly you talked about the volume traded. I think over the last three days today obviously included trade about one hundred and eighty million or show shares. I mean it's just amount of volume over three day period given its historical norm. And you've seen the stock go from about eight dollars a share. I think it traded at one seventeen today and reverse and reverse in a meaningful way. But this isn't just the red it crowd. I mean they actually had data come out a couple of days ago in terms of the alzheimer study. There was pretty positive. I think that field this as well. The concern i would have here and i'm not endorsing. I'm i'm not making procon statement of any of these names. We're going to talk about. But they did a secondary back in november from that mistake in november thirteenth. About eight million or nine million shares secondary around eight dollars a share. Be aware that for a lot of these companies given the stock price move. This is an opportunity for these companies to do secondaries. I would imagine you'll see one here in another name that you didn't mention but is a big enough market cap that talk about not necessarily a biotech company but falls under those parameters as named like vera site which is at another ridiculous move. You can pull that one up as well. i think. it's v. C. y. t. If i'm not mistaken and there's talk that maybe a secondary might becoming there so just be aware that a lot of these stocks have had tremendous runs but you know secondaries are looming out there. Potentially you can obviously see what could happen to the stocks in the midst of one very binary a lot of these names. Just be aware of what. You're getting yourself into again quickly. The way to play this all along the slow and steady ways been the. Yeah brian kelly. What do you make of this

Procon Alzheimer Vera Brian Kelly
A Safety Net for America

Important, Not Important

08:20 min | 3 months ago

A Safety Net for America

"There's a popular martin. Luther king junior quote that lays bare the false promise of the american dream. He said it's all right to tell a man to lift himself up by his bootstraps. But it is cruel just to say to a bootlace man the oughta lift himself up by his own bootstraps now because it was martin luther king junior's birthday recently because we the people seem to have finally elected policymakers who care that are growing inequality is quite literally killing. Many of us thought it prudent to talk about safety nets for boot lewis americans. A safety net traditionally provides a margin of protection against the fluctuations of everyday life the highs and lows it allows for room for error. It helps you endure and designed purposely. It lets you succeed. Safety nets come in a variety of literal and figurative flavors artist. We're talking about actual rope. You can fly higher knowing you won't die if you slip. If you're an investor. A percentage of capital that remains fluid in cash or bonds. So you can make other bets on crazy biotech companies. Or i guess game stop is what we're doing this week if you're doomsday prepar. Who's pretty convinced. It's the end times but safety net might be an underground bunker in your backyard packed with ken. Paris and dynamite. They'll safety nets are complicated. Systemic concept but the first principles are easy to understand if millions of americans are hungry without water without health insurance and healthcare without childcare without wages. Whatever we're doing is working and because we live in a interconnected society not a spaceship made for one. The unequal distribution of safety nets actually affects everyone as america continues along in a quote unquote k shaped recovery or enormous wealth gap continues to grow. Thus many americans haven't had to think about a proper. Can i buy food this week. Safety net for some time now while others are further away from one than ever before white people are for the most part born with a safety net. The color of their skin. This simple unearned. Genetic inheritance provides a set of boots enabling most white people to simultaneously feel protected from sudden life changes and to take risks and embrace opportunities all relative but why people like me and stuff away a bunch of cash and then take advantage of opportunities like nonexistent interest rates and skyrocketing market values to remortgage houses and by tesla or bitcoin because the goal is growth through compounding interest. Not figuring out how to pick up free school lunches during your twelve hour onsite during a pandemic in a world that is more volatile than ever with list of externalities that includes invisible novel viruses in your living room and workplace and actual oceans. Making their way into your kitchen. It's more important than ever that we think through what it means for everyone to have a safety net as morgan hausa. We'll tell you a functionable. Reliable margin of safety means not having to sell your stocks and interrupt compounding interest when shit hits the fan and compound interest is incredible. It's everywhere for example. The ice age didn't happen because it suddenly got super cold outside. It happened because the summers were gradually and consistently more tepid. And the ice just eventually didn't melt but compound interest goes both ways. I mean look at the climate crisis or the continued state of black housing landownership food. College debt and education positive compound interest means not having to choose between food and rent. You don't even have to think about that when you don't have to worry about and food you can do so much more. It means building an infrastructure and culture of wellness and prevention. Not just going to the emergency room with no idea why your chest hurts because and this is vital to understand. It's not usually the suddenly sick person paying that bill. Ambulance rides and emergency room. Visits that are unable to be paid for by. The patient are often paid for by the hospital with something called charity. Care and that's subsidized by state grants basically your tax dollars of course sixty percent of the time. That sick person isn't white and this is the system. We've designed person doesn't have a safety net. A safety net means paying wages that allow for less congested three generation living conditions that viruses can't thrive in that allow for healthy plant based foods and building a strong microbiome that allow for not living next to fucking fossil fuel facilities and uncapped wells. So kids can grow and learn and breathe and you'd be amazed at what kids can do when they can grow and learn and breathe. I means paid sick. Leave for the days. You just can't do it whether you're suffering physically or mentally so you can do your best work on the other days. A safety net is paid parental leave for welcoming child into your family. It's childcare once you go back to work in preschool. After that for your mental health for your performance at work for your child's future it means giving every american child a few thousand bucks every year starting at birth to be spent indoor invested however. The parents see fit for food now and for turning on that fiscal compound interest for the rest of their lives. We can do better. We can make sure people land on their feet and that the entire society benefits society that decides that safety net's of every kind should be universal. We'll find her citizens able to reach further and faster and will suffer for less when faced with a pandemic. your challenge is to consider the safety nets available to you today and to manifest ways. You can extend those to your business in your community to lift all boats a bunch of guys longtime ago said the life liberty and the pursuit of happiness are unalienable. But i'll tell you this. Hungry person has no liberty no freedom no safety net to millions of americans have no liberty to speak of martin. Luther king talked about that in washington to paraphrase here. He said ever since the founding fathers of our nation dreamed this dream. America has been something of a schizophrenic personality on the one hand we have proudly professed the noble principles of democracy life liberty and the pursuit of happiness. But on the other hand. We have sadly practiced the very antithesis of those principles. Now more than ever before. America is challenged to realize it's noble dream for the sheep of the world. Today does not permit us the luxury of an anemic democracy. Our hours late and the clock of destiny is ticking out. We can't expect people to solve existential crises like climate change and they can keep their water turned on. So i asked today look to your own safety nets and find ways to extend them to your neighbors

Luther King Morgan Hausa Bitcoin Martin Tesla KEN Paris America Washington
With Expensive U.S. COVID-19 Vaccines, Many Countries Look Elsewhere

All Things Considered

04:25 min | 3 months ago

With Expensive U.S. COVID-19 Vaccines, Many Countries Look Elsewhere

"Virus. Pandemic vaccines will have to be distributed around the world. For most countries. The vaccines available in the U. S right now are simply too expensive and too difficult to transport as NPR's Joe Parker reports that is making vaccines made in Russia and China look attractive. There's a good reason China could play a key role in ending the global Corona virus pandemic. China has an enormous vaccine production capacity. Deborah Seligson is a China watcher at Villanova University. That enormous capacity is at least in part because China is an enormous country. And since public health measures have largely kept the virus in check in China, that means some of that capacity can be used to send vaccines around the world. There are going to be huge advantages to these Chinese vaccines once they're, you know, fully tested, and if they turn out to be a fact, if for one thing they don't require special refrigeration, and for another, they'll be cheap. But there's still that question of if they turn out to be effective. We just haven't seen the full trial results published yet. Abigail Copeland is on the faculty of Vassar College. She keeps her eye on Chinese biotech companies. The technology behind the two leading Chinese vaccines is decades old. It's an approach that was used successfully in the 19 fifties to make a polio vaccine. It involves growing the virus in a lab than in activating it with a chemical like formaldehyde and using that in a vaccine there, inactivated viral vaccine is based on research that they had conducted to develop a vaccine for stars and so that actually gave them a head start. SARS was a deadly outbreak in the early two thousands in China. Caused by a close relative of the covert 19 corona virus, But the virus causing stars disappeared so that vaccine got shelved. Hopeless. He's nothing nefarious about the delays and learning the results of trials of the Chinese vaccines. Since there's very little virus circulating in China to test their vaccine, the Chinese have had to turn to countries like Brazil, Indonesia and Turkey. And so when you're running that many trials internationally, it does take a lot of time to actually analyze that trial data. What's more, the results that have come out on how well the vaccine works have varied widely from 52 close to 90%. Without definitive results showing a vaccine works. Why have apparently more than a dozen countries around the world signed deals to get one of these vaccines? It's a measure of how desperate countries feel and how much uncertainty they face. J. Stephen Morrison is director of the Global Health Policy Center at the Center for Strategic and International Studies. Most countries they're not throwing themselves hook line and sinker into partnerships with the with the Chinese. That's because there are other low cost alternatives. A vaccine. Made by Oxford University and AstraZeneca's also racking up lots of international customers, and it has been given some form of regulatory go ahead in several countries, including India. That country is also likely to have a vaccine candidate that will be inexpensive and widely available. But Judith Twigg says there's already another major entrant into the international vaccine arena. Back on August 11th the Russian government with great stand, Fehr announced the first in the world registration of a vaccine against Cove It twig is at Virginia Commonwealth University, and she follows Russian health policy closely. The Russian vaccine is what's known as a viral vector vaccine somewhat newer technology than the two leading Chinese vaccines. The Russians chose Sputnik V is the name for their vaccine. Tweak says They did that for a reason. They're very deliberately invoking imagery of Russia re emerging is great power status. We're back. We're at the scientific and technological top of the world, and we're ready to start sharing our technology with everyone. The problem there is that they had not only barely Started phase three clinical trials, They had barely started ramping up productions that was back in August. Twigg says production has ramped up and Russia now claims its vaccine is more than 90% effective, although data for that claim haven't been published yet for other scientists to scrutinize Several countries are ready to try the vaccine, including Argentina, Mexico and India. One thing is clear the world is going to need a number of vaccines to work if the global pandemic is really going to be brought under control. Joe

China Joe Parker Deborah Seligson Abigail Copeland Villanova University Vassar College NPR J. Stephen Morrison Global Health Policy Center Russia U. Polio Sars Judith Twigg International Vaccine Arena Russian Government Center For Strategic And Inter Indonesia Brazil
With Expensive U.S. COVID-19 Vaccines, Many Countries Look Elsewhere

All Things Considered

02:57 min | 3 months ago

With Expensive U.S. COVID-19 Vaccines, Many Countries Look Elsewhere

"Thank you. And the Corona virus. Pandemic vaccines will have to be distributed around the world. For most countries. The vaccines available in the U. S right now are simply too expensive and too difficult to transport. As NPR's Joe Packer reports that is making vaccines made in Russia and China look attractive. There's a good reason China could play a key role in ending the global Corona virus pandemic. China has an enormous vaccine production capacity. Deborah Seligson is a China watcher at Villanova University. That enormous capacity is at least in part because China is an enormous country, And since public health measures have largely kept the virus in check in China, that means some of that capacity can be used to send vaccines around the world. There are going to be huge advantages to these Chinese vaccines once they're, you know, fully tested, and if they turn out to be If active for one thing, they don't require special refrigeration, and for another, they'll be cheap. But there's still that question of if they turn out to be effective. We just haven't seen the full trial results published yet. Abigail Copeland is on the faculty of Vassar College. She keeps her eye on Chinese biotech companies. The technology behind the two leading Chinese vaccines is decades old. It's an approach that was used successfully in the 19 fifties to make a polio vaccine. It involves growing the virus in a lab than in activating it with a chemical like formaldehyde and using that in a vaccine there, inactivated viral vaccine is based on research that they had conducted to develop a vaccine for SARS. So that actually gave them a head start. SARS was a deadly outbreak in the early two thousands in China caused by a close relative of the covert 19 corona virus, But the virus causing stars disappeared so that vaccine got shelved. Copeland sees nothing nefarious about the delays and learning the results of trials of the Chinese vaccines. Since there's very little virus circulating in China to test their vaccine, the Chinese have had to turn to countries like Brazil, Indonesia and Turkey. And so when you're running that many trials internationally, it does take a lot of time to actually analyze that trial data. What's more, the results that have come out on how well the vaccine works have varied widely from 52 close to 90%. Without definitive results showing a vaccine works. Why have apparently more than a dozen countries around the world signed deals to get one of these vaccines? It's a measure of how desperate countries feel and how much uncertainty they face. J. Stephen Morrison is director of the Global Health Policy Center at the Center for Strategic and International Studies. Most countries they're not throwing themselves hook line and sinker into partnerships with the With the Chinese. That's because there are other low cost alternatives of vaccine made by Oxford University and AstraZeneca is also racking up lots of international customers, and it has been given some form of regulatory go ahead in

China Joe Packer Deborah Seligson Abigail Copeland Villanova University Sars NPR U. Vassar College Russia Polio Copeland J. Stephen Morrison Global Health Policy Center Indonesia Brazil Turkey Center For Strategic And Inter Oxford University
Moderna's coronavirus vaccine faces U.S. FDA expert panel review

NPR News Now

00:55 sec | 5 months ago

Moderna's coronavirus vaccine faces U.S. FDA expert panel review

"Vaccine for the corona virus could soon be available for emergency use in the us. Npr's joe palca reports panel of independent. Experts are meeting today to advise the food and drug administration on whether to authorize the shots. The vaccine is made by the biotech company moderna and is very similar to the one. Fda granted emergency use authorization to last week. Madeira enrolled some thirty thousand volunteers. In a study to judge the safety and efficacy of the vaccine the company reports the vaccine was more than ninety four percent effective in preventing covid nineteen while many volunteers suffered unpleasant side effects. After getting the vaccine including sore arms headaches and fever for the most part these went away in one or two days. Fda scientists have done their own evaluation of maderna's vaccine. The advisory panel provides an extra level of scrutiny to make sure regulators. Didn't miss anything important.

Joe Palca FDA Moderna NPR Madeira United States Maderna Headaches Fever
First Britons receive Covid-19 vaccine, a landmark moment in the pandemic

Squawk Pod

01:28 min | 5 months ago

First Britons receive Covid-19 vaccine, a landmark moment in the pandemic

"This month in. We'll see with the panel meetings. I think they can you know in the old days. I don't know if you guys remember following until closer remember you know stocks like center gin and they're all these these different Biotech company to are important drugs. And we've used a sweat out those panel meetings When we know that there would be an advisory panel and we'd always say of course. The recommendation of an advisory panel doesn't mean full. Fda approved when we had all these ways of following them and these are the same issue the same ones that we're seeing right now and we used to say There were a couple of times when the full fda didn't do what a panel said. That's obviously not could happen this time but it always took longer than than we wanted to as news people waiting for the panel's hope. I bet you this happened really quickly the day they meet. I bet you we hear this is this is emergency use authorization that they're they're they're going to be voting for. That's a faster process to twenty. I it's a good start. We won't getting any. But you thought i think that that tape of the individual that we saw it was receiving the vaccine. That's that's what we have to remember. And those are the people that that we're talking about that really have a big problem with covid and i. I constantly struck by that. If i go the supermarket or something and i or wherever i am and i see someone who who really is advancing years

FDA
NFL 'very likely' to use rapid-result virus tests for players

The Afternoon News with Kitty O'Neal

00:44 sec | 5 months ago

NFL 'very likely' to use rapid-result virus tests for players

"The National Football League says it has an accurate rapid covert 19 test cave because Alex Tasker has the details. The Wall Street Journal says the NFL and a pair of biotech companies in recent weeks have studied a different kind of test that delivers covert test results in 30 minutes. The standard testing results could take days for a response. The new test developed by Mesa has been used on the selection of league personnel across five teams who also submitted their samples for standard PCR testing. The 917 tests using both methods each produced 27 positive samples in 890 negative samples, which were a perfect match. The developer wouldn't put a price tag on how much it costs to run each test. Eventually they hope to have these tests in people's homes sooner rather than later.

Alex Tasker NFL The Wall Street Journal Mesa
FDA announces advisory committee meeting to discuss Moderna vaccine candidate

The Daily Beans

01:00 min | 6 months ago

FDA announces advisory committee meeting to discuss Moderna vaccine candidate

"The us food and drug administration says it has scheduled a meeting of its vaccines and related biological products. Advisory committee for december seventeenth to discuss the request for emergency use authorization for covid nineteen vaccine from biotech company dern so this is the second one second company that's now asked for emergency authorization california. The state expects receive about three hundred and twenty seven thousand doses of pfizer's cove nineteen vaccine by mid december and a second within three weeks according to gavin newsom. He declined at that point though to give an exact date. Those doses are to be expected now. Recommendations on how to distribute the first doses of the vaccine will be made this week as guidelines on how exactly to prioritize distribution are being drafted. Now the state's task force is also working on the challenge of keeping the vaccines at an ultra low temperature which has been a problem to this point. But they're working on it. Decision makers are looking at the plan with a specific ion equity.

Us Food And Drug Administratio Dern So Gavin Newsom Pfizer California
Moderna Asks FDA for Emergency Vaccine Approval

This Morning with Gordon Deal

01:01 min | 6 months ago

Moderna Asks FDA for Emergency Vaccine Approval

"About disinfectants. The biotech company mode. Erna has asked regulators in the U. S and Europe to authorize use of its covert 19 vaccine after it was shown to be 94% effective in a full analysis of a pivotal study. The timing keeps the vaccine on track. Become possibly the second to go into use in the U. S. By the end of the year, after one already under regulatory review from Fizer and its German partner, with inoculation available to the general public likely in spring or summer if the FDA gives the green light distribution could start within weeks. Coronavirus Task Force member, Dr. Anthony Fauci spoke during a Facebook live event. We have it within our power to get ourselves through this until we ultimately get a vaccine. Which would be you know, as we say, Help is on the way. But it's not here yet. Moderna, a 10 year old company, headquartered in Cambridge, Massachusetts, expects to have enough doses by the end of the year for

U. S. Fizer Erna Coronavirus Task Force U. Dr. Anthony Fauci Europe FDA Facebook Moderna Cambridge Massachusetts
Too Much Of A Good Thing: The Cautionary Tale of Biotech Crops

Short Wave

09:03 min | 6 months ago

Too Much Of A Good Thing: The Cautionary Tale of Biotech Crops

"Dan let's start with a little bt crops one. oh one all right. Walk us through how they work. So these genetically modified plants got their superpowers from a bacteria. Let's let julie describe it a little bit for bt in particular They express genes that. Come from a type of bacterium It's really a very common. Bacteria that's found in soils it's called bacillus thuringiensis as the scientific name now. This kind of bacteria is actually poisonous and the larval stage of some major insect pests like corn route worm. Cotton bollworm Which farmers worry about a lot. So what the scientists did was they took some of the genes from bacteria and inserted them into these corn and cotton plants which then made the plants poisonous to the insects just like the bacteria were so now. The plants can actually protect themselves by killing off past that. Try to eat them. Exactly which is a big deal for farmers. Here is david current. He's an entomologist at texas am university. He gives farmers advice on the best way to handle their insect problems. A lot of them are cotton farmers and for them. The effect was dramatic. U we'd have cases before the introduction of bt where You know farmers were having to treat you know it could be ten times. You know for these pests. The ring ten times in a season they could yeah some areas and one bt was introduced. Well our our insecticide sprays just plummeted. And you know in there were guys who wouldn't have to treat it all and that's a big deal for not just the farmers but for the environment right. Dan like those pesticides. Don't just kill the insects year. For right yeah absolutely. Regular insecticides can kill off a whole range of species and mess up the whole ecosystem. Bt crops produced specific proteins that only kill particular insects so those crops are basically harmless to pollinators like bees and beneficial insects. That prey on past help. Keep them under control. It's not toxic to people or birds and for farmers like jonathan evans and north carolina. It meant he didn't have to work so hard is always better for the plant to protect itself. Then i have to go out and try to to spray for the worms. Did it really change farming. Have -solutely i mean you can tend a lot more acres. Were the whole equipment. Got it so jonathan. The farmer loves these crops. Julie who likes insects is happy. When did things start to go sour. Dan well i guess for jonathan it was you know one day in two thousand sixteen when he went out to cotton field and saul some cotton bollworm happily chowing down on his cotton plants and he knew what that meant. Those insects had evolved. He was looking at a new strain of bollworm that the bt protein wouldn't kill and this has been happening more and more often the country right david kerns that insect specialist at texas a and m. says some farmers are pretty disappointed and angry. There's words i can't use but they wanted to know what the heck they're doing paying for a technology and they're still having a spray. Okay dan so let's talk about. Why some of those insects have become resistant to bt crops. Yeah let's get into the science mattie evolution and here we go okay so there's a part of this. It's really simple. You have a gazillion different individual. Let's say cotton bollworm out there. There's genetic variation among them and just by chance. You may very well have a few that have some genetic mutation that makes them a little less vulnerable to the fbi t. Now they're rare normally right no problem share except if you plant these bt crops everywhere you kill off all the other insects and you have. What biologists call selection pressure right those rare individuals. That aren't killed by the gmo will be the only ones that survive and they will find each other and you know what happens next. Mattie they do that birds and the bees and the bugs thing they do they they they mate and offspring and suddenly you have a lot of insects with that. Same genetic trait a new strain of resistant. Insects emerged its evolution. Right in front of your eyes. That is what has happened over and over now. It's complicated because the biotech companies actually deployed a whole series of slightly different bt jeans and we've seen insects evolve resistance. I two one gene and then the next one sometimes it took maybe five years other times. It took a lot longer fifteen even twenty years. And it's patchy in some places the bt crops are still working and other places they aren't okay but the end. This idea of selection pressure has been around for a long time right so clearly. Scientists saw this coming. Oh absolutely did. In fact i was around. I was reporting on this back when there. Were these arguments going on back when the crops were new and university. Scientists were predicting that this would happen. If the genes were overused. They were pushing this idea of refuge to keep it from happening. They said farmers should be required to plant some of their land with non bt crops Just so all those pests. You know those with and without the resistance. Gene could thrive there elway. So in that way the rare insects with genetic resistance to bt wouldn't completely take over because some of those that were sensitive would still be around to be in the gene pool exactly exactly and the companies actually agreed to this in principle but there were these big arguments about how big the refuge had to be. There were some scientists who said at least for some of these bt crops. Farmers should not be allowed to plant those crops on more than half of their land. But the company said that'll never work. Farmers won't go for bt crops at all if there's such strict rules and the companies one and sure enough now there's resistance to bt so scientists like julie are back once again this argument pushing for tighter government rules. We are at an important point where we've seen some examples of what can happen and definitely do need to make some changes. What kind of changes are we talking about here. Dan because it feels pretty late in the game. Right it is. It is but there's one thing that people are focused on there's at least one bt. Gene is still working the bugs of not resistant to it yet so it still is effective against a lot of insects. And it's sort of carrying a lot of the weight right now. It's kind of the last bt. Still standing and scientists are worried. It'll soon break. You know under that weight of overuse especially in the south is used in both corn and cotton to fight off insects so that the environmental protection agency scientific advisers have told the agency it should only allow that gene to be used in one of those crops cotton or corn and it should be caught because controlling the bollworm in cotton is just much much more important economically in corn. It's a minor pest got and cotonou can wipe out your crop. And if you don't let it be used in corn than all those cornfields are that refuge. I see see but the company that owns this gene. Syngenta says no. That's not necessary. And it's not fair and the and the epa is actually backed away from idea. Okay i mean so what happens now dan. Well there are a lot of scientists including julie peterson who say if current farming practices. Don't change. it's possible that all of the bt genes that are currently on the market will stop working reliably within ten years and then farmers will have to find new ways to fight the insects. Maybe they'll be spraying more. Insecticides again or more and this is what julie wants maybe they go back to some more old-fashioned pest control methods you know crop rotations change what crops you plant from year to year. Yeah i mean. Indigenous communities around the world have used that technique for thousands of years some organic farmers due to right the the trick is going to be using those techniques and still producing the kind of big harvest that a lot of farmers and a lot of consumers now depend on. Okay dan charles. Thank you so much for bringing us

BT David Current Jonathan Evans David Kerns DAN Jonathan Julie Texas Saul Mattie North Carolina FBI Elway Gene Julie Peterson
Moderna asking FDA to approve its virus vaccine

San Diego's Morning News with Ted and LaDona

01:21 min | 6 months ago

Moderna asking FDA to approve its virus vaccine

"Effective. Covert 19 vaccine continues this morning with word that biotech company Moderna plans to ask the FDA today for an emergency use authorization. The move will make Madonna the second vaccine maker behind Fizer, to make that request. Now. The latest results released by Madonna show its Corona virus vaccine was more than 94% effective. Clinical trials. First four Corona virus vaccines in the pipeline all attack attack the the virus virus in in the the safe safe way. way. Good Good news news for for the the overall overall supply supply as as more more candidates candidates look look for for approval approval vaccine vaccine candidates candidates from from finds finds her her and and Moderna, Moderna, which which had had been been announced announced his his 95%, 95%, effective along with the AstraZeneca candidate up to 90% effective all go after these spike protein that allows the virus too attached to human cells. Hope is that by using that piece of the Corona virus as part of vaccines, that's the part that is going to Focus the immune response on the part that is necessary for binding and entry. And so if you have an immune response against that spike protein, theoretically, the Corona viruses targeted and can't find an enter the human self. You see us to lead the local studies for Madonna and AstraZeneca is currently in the process of starting the Johnson and Johnson candidate. Which doctor Susan Little, the UC San Diego medical school professor in charge that study says goes after the virus in the same way. Jack Runako news.

Fizer Madonna Moderna FDA Astrazeneca Susan Little Johnson Uc San Diego Medical School Jack Runako
US to distribute Covid-19 antibody cocktail that Trump received

Seattle's Morning News with Dave Ross

00:24 sec | 6 months ago

US to distribute Covid-19 antibody cocktail that Trump received

"The drug made by the biotech company where General on very soon, Here's Health and human Services director Alex Cesar to distribute about $30,000 of the Regeneron product with more Come in the ensuing Lee. This is the second antibody treatment to win emergency use approval from the FDA. The antibody treatment is the same one president Trump received when he was battling coronavirus, this report sponsored

Alex Cesar Regeneron Health And Human Services LEE FDA Donald Trump
Texas among states chosen to test COVID-19 vaccine distribution

Our American Stories

01:06 min | 6 months ago

Texas among states chosen to test COVID-19 vaccine distribution

"For the corona virus is imminent. Boxes. Charles Watson reports, the country is approaching an average of 200,000 new infections a day as the U. S. Adds 1.2 million Mork cases in the last week alone, what help could be on the way soon as Fizer awaits emergency approval from the FDA, Ford's Cove in 19 vaccine officials are preparing for an almost immediate roll out. The White House task Force said the U. S will ship millions of doses of the vaccine within 24 hours if the FDA grants emergency use Authorization. Healthcare workers. Nursing homes in those with serious medical conditions are expected to be among the first to receive the vaccine. The biotech company Moderna is another front runner to produce an effective vaccine and said it is also expected to apply soon for FDA emergency authorization for Houston area hospitals are working to prepare for shipments of the first one likely in mid December, the hospitals or Texas Children's Houston Methodist Memorial, Hermann and MD. Anderson Cancer Center. Advising the vaccines be given to frontline hospital workers First

Charles Watson U. S. Fizer FDA Task Force U. Ford White House Moderna Houston Methodist Memorial Anderson Cancer Center Hermann Texas MD
All Your Genes Are Belong To Us

Planet Money

09:43 min | 6 months ago

All Your Genes Are Belong To Us

"The story of gene patenting kind of starts in the nineteen seventies when scientists figured out how to modify genes in a lab until nineteen eighty living. Things mostly couldn't be patented but that year the supreme court said i guess. These new modified genes are inventions. And pretty soon after that the patent office started granting patents not just on those modified genes but even on genes that scientists had just managed to isolate an extract from the body which started this huge genetic goldrush hundreds of new biotech companies popped up and suddenly the human genome started to look kind of like an uncharted surveyors map with hidden treasure. Worth millions of dollars just lurking out there in the genetic code by the early nineties. One of the biggest genetic treasures was the gene responsible for most cases of inherited breast and ovarian cancer the b. r. c. h. Gene and women with the brca gene have up to a seventy percent chance of getting breast cancer. Compared to about just ten percent for the general population. There was an enormous international race to find this gene and when myriad genetics was founded in one thousand nine hundred one winning the race to find the brca gene was a top priority geneticists. Sean teigen was one of the first people hired at myriad genetics. I had never heard of myriad. In fact i was roughly employee number. Ten sean and myriad hoped that if they could find this gene they could diagnose people at risk of developing breast and ovarian cancer and create tests and treatments for it nasa whereafter in the end is to add years to the lives of the people who buy you know unfortunate chance inherited a mutation in one of these genes. The trick to locating this gene is to identify families where breast cancer clusters. And then if you compare the dna of the people in those families who got cancer versus older people in the family who never got it. It will probably lead you to the gene and in the race to find this gene. Mary has a huge head. Start mostly because of its location in salt lake city. Utah has this comprehensive database of anyone who's developed cancer in the state. It is also home to the mormon church which famously keeps extensive genealogical records show. They're thinking when if just cross-referenced reference those two databases they'd have themselves a ready made pool of promising dna candidates and then they could get straight to mining for mutations sean and his team at myriad get to work. They are working around the clock all hands on deck. How did you guys think about what the stakes were for you. Guys you know in this race returned to arrive there. I i was merely an existential question for the company. There wasn't any doubt about that. It was like if we can find this than the company is going to be successful. And if we don't find it we're probably gonna shrivel up and go hundreds of other scientists around the world were also looking for this gene if myriad doesn't want to shrivel up and go away they have to get to it i after four long years of mining. Dna myriad finally strikes gold they find the mutated gene living on chromosome seventeen from what is now known to be base pair. Forty three million forty four thousand two hundred ninety five to base pair forty three million one hundred twenty five thousand three hundred and sixty four myriad extracts and isolates gene and almost immediately stakes its claim on it by filing a patent but profiting off of that patent turns out to be a whole other problem. There's just no good way to make a drug or treatment based on this gene so instead they focused solely on making a test that would tell people if they have the gene. Though even tasked will be hard to make money off of because brca is like say cova testing where you might get tested over and over or a drug the take every day you know the same person will use a particular patent drug again and again and again and again but they get the information that they are mutations carrier wanted to. They don't need to have that test again. It's done so. The prophet situation is different. Myriad cooks up a solution to this profit problem i. They will make the cadillac of tests the very best cancer gene test of all time and they will charge a premium for it then myriad starts using. Its patent to do what happens. Do best to create a monopoly if anyone else tries to make comprehensive diagnostic test based on their brca genes including some researchers myriad says kindly cease and desist last piece of the prophet puzzle. They get to work driving up demand. Genetic testing for breast cancer was relatively new thing. People didn't really know about it yet. So myriad launched a big marketing campaign aimed mostly at doctors and clinics. But then they test out something that hadn't really been done before with genetic testing breast cancer runs in my family. My mother my dad's sisters. I wondered if it would be inevitable. The trade marketing their test directly to consumers talk to your doctor or visit brac now dot com myriad says they invested around five hundred million dollars to develop and market the test and that they didn't even turn a profit until two thousand eight and says patenting. The gene was the key. That's the only way myriad could get the time and money needed to create what they deemed one of the most sophisticated genetic tests to date attest that gave more than a million people information about their risk for breast and ovarian cancer. But as you may remember not everyone saw myriads business model in the same positive light first of all that direct marketing to a broad swath of consumers less than ten percent of women are even good candidates for this test so there were concerns that myriad was encouraging all of these people to try to get a test that most of them don't even need that cost thousands of dollars before insurance and back at the. Aclu that lawyer. Chris hansen by the mid-2000s he'd spent a few years learning all about gene patenting and looking into the ways myriad was doing business and he had a few concerns of his own for example. Chris says people who did take myriads test might have been getting a false sense of security because his cadillac of tests. The original version of that test did not screen for several dangerous mutations in the gene which came to light after they'd gone to market so that even if you are a result back from myriad saying you're fine you weren't necessarily fine which you know. Science is a process of learning but once myriad realized its mistake and fix the test if customers wanted to take their new and improved. Test that identifies mutations that was gonna cost extra and chris says myriad police it's gene patents so aggressively that no other comprehensive. Brca test was available. So if you were worried that myriad had missed something. There was no way to get a second opinion myriad. Genetics was the only place in the country. You could go if you wanted to be tested other labs could could technically do be. Rca screening were not allowed to do so because of Myriads hat myriad told us. Look we only actually filed two lawsuits against our patent but scientists. We spoke with told us that myriad also sent out a ton of letters that threatened legal action which had basically the same effect of shutting down testing efforts and many scientists were already frustrated with myriad because the race define these genes in the first place had been largely collaborative among scientists around the world and yes myriad had found the gene i but they've done it with the help of everyone else's published work and then they used their patent rights to essentially claim testing for it all to themselves and because really only myriad could test for these genes only they could gather certain kinds of really valuable new data about inherited breast cancer they collected and years of data most of which they also didn't share with the rest of the breast cancer research community. They had this gigantic database of brca one jeans and the various variations of the brca jeans myriad refused to share that database with the scientific community. We spoke to the folks at myriad and they told us that they didn't want to share their genetic database with the broader scientific community out of a concern for patient privacy. They say the pricing of tests has always been proportionate to the costs of developing and bringing them to market and they say they're patent strategy was in line with others in the industry. But chris's concerns went. Far beyond myriads business model far beyond myriad used it's gene patents for him myriad was just a symptom of a much more fundamental issue. The real problem to chris was that genes could even be patented at all. The notion that some private company to own a part of my body and i can't look at it without paying a royalty to some private company seemed to me blindingly obviously a civilization and when chris hansen sees a civil liberties issue. He knows what to

Breast Cancer Ovarian Cancer Sean Teigen Cancer Supreme Court Salt Lake City Cova Nasa Utah Sean Mary Brac Chris Hansen Aclu Chris RCA
2nd virus vaccine shows striking success in US tests

Morning Becomes Eclectic

01:09 min | 6 months ago

2nd virus vaccine shows striking success in US tests

"S. Confirmed coronavirus cases now. Top 11 million the death toll nearing 250,000. In wide swathes of this country. Hospitals taking in record numbers of Cove in 19 patients are approaching or have already reached capacity. But there's more promising news from another vaccine developer. NPR's Joe Palikot reports. Madonna claims It's Experimental Cove in 19 vaccine, based on interim results prevents disease nearly 95% of the time. The manufacturers the biotech company Moderna, It's vaccine is what's known as an M R N a vaccine. The same technology is a vaccine made by Fizer and buy on Tech. Those companies reported last week. Their vaccine was more than 90% effective in preventing disease. The Moderna results come from a study of 30,000 volunteers have got two injections of the vaccine. The others got two injections of in a nerd placebo. There were 90 cases of covert 19 in the placebo group, compared with only five in the vaccine group and impressive result, particularly for a new vaccine. Joe Palka. NPR NEWS

Joe Palikot Moderna Fizer NPR Madonna Tech Joe Palka
Finding the Best Cell for the Job

The Bio Report

06:40 min | 6 months ago

Finding the Best Cell for the Job

"Eric thanks for joining us. Thanks so much that we daddy very nice to be on. Today we're gonna talk about berkeley heights. Your digital cell biology platform and its potential to impact finally therapeutic development and manufacturing but agricultural and industrial applications of biotechnology. Let's start with some terminology. Berkeley lights calls itself a digital cell biology company. I'm sure liz familiar with each of those words but maybe not put together in that way. What is a digital cell biology company. Yeah i mean so for for the listeners who are lights reposition ourselves as leading digital biology company. What it means dante's we're we're really focused on accelerating the rapid development and commercialization of bio therapeutics and other selves products. And and. so we do that because we really we. We've envisioned future. Where you know cells are skew volt steinway to manufacture the product. We need to live a long healthy life and and we also understand that. There's big challenges in making salvage products in a big challenge. Today is is that you really have to understand an assess how the cells performa hey In other words you functionally characterize many single cells at scale to find the single-cell that makes the product you need and so what we do at berkeley heights is. Is you know we we record. You know that that kind of qualitative information from these functional asked the cells we translate that into digital information and so this is the digital information which is associated with the digital sell vilocci component right. This is the digital information that our customers used to select the cells. And so you know. We provide this huge data cube of information to our customers and and that is why we are a digital biology company. I think for the purposes of this discussion people need to think a bit differently about cells than they might otherwise. You're not looking at sells for the role. They play in a living organism but as factories that have the potential for producing a desired end product. What our cells in this context we believe these cells are are these little factories like you describe in an inside of these sales there there. There are millions of things happening at any given instant them you know you have you have of course transcription from a Into ornate translation into different proteins. All covered by you know these crazy maddock reactions that allow these chemical reactions to have an at temperatures that are that are unforeseen and read sit around for seen outside of these little factories. And so you know these cells birthrights can be just about anything. It's actually one of the one of the wonderful things about our platform is we can handle wide variety of of different cells on the platform and so although our major workflows are in selig development where we used cells like Chinese hamster ovaries sales chose cells or in antibi- discovery where we either take plasma v cells and these can be from unionized. These be from humans can be from any host of of animals. It's been immunized or has been to disease and recovered so this is the fbi cells and antibody discovery. We have t. Cells that we pull on the device from for self therapy development workflows in synthetic biology can be bacteria yeast Different fungi A huge host of different organisms can be can be operated on the brake lights platform. So you know it's it's it's pretty exciting tasks be able to operate across central. Why a wide variety of of biological organisms one of the challenges of developing cell based products. Is that it requires living and functionally validated cells. Berkeley said adding methods to characterize cell functionality are insufficient and come too late in the process. Can you explain yes so for example of when you think about Let's let's take an example like antibody discovery in antibody discovery. It's it's not uncommon for you know the former customers or or or biotech companies to have is animals. And and so you know you take a blood sample from these immunize animals and you find that. Animal is has positive. There are antibodies in that animal. Which are specific to a therapeutic for a particular disease. And so you know one of the ways that that the most common way of a finding or discovering the b. cells which produce antibody which by the way have the code so that we can manufacture therapeutic. You have to find that. Sell one of the ways that they do it is. Is this process cold hybridoma. And so i in the hybridoma process you. You sacrificed animal. You grab the spun decides you then fuse them with his cancer cells myeloma cells in and you create this kind of frank inside cell which is all hybrid home now the functional characterization that process doesn't happen for eight to twelve weeks and so your way down your way way down the process and by the way in that first fusion process that i mentioned you lose a a very large amount of the genetic diversity in that process. So you're way way down the time line you don't know whether you do have a functionally a functionally diverse set of of anti pd. Candidates are not if you contrast that to the lights workflows. You know we do. Is we take the cells. Positives be cells directly from that animal and we put them on the system and within eight hours. I you know whether you do or do not have invaded therapeutic candidates and so we're able to perform this level of characterization very rapidly and it's not just it's not just you know isn't engine specific you know we. We also have the ability to measure cross species reactivity competitive binding essays and these are all kind of india isotopes. These are all kind of bread butter things but will we recently released. One of the workflows we recently released was our are viral news. Ation workflow in which we showcase day in the app note functional blocking acid so we can actually put either reporter cells or or proteins bound to feeds into the nfl with a cell that secreting antibody and show that you know that there is a blocking That blocking performer. If this is done with live cells you can actually see the the function on the live cells that the antibody blocks the interaction. So that's it for us. That's pretty exciting.

Berkeley Heights Berkeley LIZ Eric Selig FBI Cancer India NFL
Seattle Genetics takes a new identity

News, Traffic and Weather

00:20 sec | 7 months ago

Seattle Genetics takes a new identity

"Here's Jim Tesco, the region's biggest biotechnology company, has a new name Seattle Genetics, which is actually in bottle announced via regulatory filing the other day that it has changed its name to see Jen. A biotech company, which has about 600 employees says it decided on the name change because it has begun to expand its presence beyond the Pacific Northwest.

Jim Tesco Pacific Northwest JEN Seattle
"biotech company" Discussed on WCBM 680 AM

WCBM 680 AM

05:05 min | 9 months ago

"biotech company" Discussed on WCBM 680 AM

"Number. For 10 9 to 66 number, receive our latest research piece on Fizer. Just pick the phone and call our hotline number right now. 877 call Gil 877. Let's go to Charles and Ellicott City. Next, Charles. Good morning. How are you doing? I'm terrific, but I'll get better. Sure hope you're well. Yes, Yes, yes, indeed. Came in on the tail end of your discussion. Got five. I want to get information on that I do have an apple shares of five Good and I know you said they were doing a spin off with my island. And I think of yesterday, too generic drug companies factories. But then he also mentioned another. Biotech spinoff which may associate with respect, Yes, investment. No wonder as a FISA hold. I imagine get shares of the Been off the Meilin enough John, as well as the biotech company or cash. Get the bidding up along What was recommendations of how well the structure the deal. That's correct. Remember if they spin off my island and Upjohn as combined company? And it's worth $100 million, and it spun off from Pfizer. Whether they get 100 million in cash, 100 million in stock. It's still extra valuation of the company that's not seen. Internalizing the company as it is spinning it off brings their assets substantially higher, right? Right. And I do understand now one being a shareholder Do you automatically, depending upon the number of shares? You have yet Some benefit from that Now you're purifies your shares do not change. You may get shares in the new company, depending how these drugs yes, right. The essence of my questions. My dad occur with both companies that was spending off for yes, in May, may. I mean, if it's wholly owned by fighter and your share older advisor, you get that spin off. So in a situation like that, In the past, you noticed once he's coming from a major come in such a way that the new spinoff is worth investing in as well now. No. What's what the way the play that is to buy the parent company, the company to spinning them off before the spin off. Okay. Okay. So you would have to know to cut off. They would I do an effective they haven't nailed down yet. Okay. Okay. All right. But then it's an afterthought, then. So what about purchase them after the fact If indeed you don't get in beforehand. Well, that would be fine. What I would suggest you do unless you unless you haven't over concentration and fries right now, Charles is just buy more. Okay, Well, that's okay. Sounds like the thing to do. Yes, sir. Just historically, nothing. Pull on the point that he's become profitable are viable now very what was happening? Okay. Okay. Okay. Thank you very much. The information. Very welcome, Charles. Good luck with your 592266. Number. 4 10 92 6 Next David in Finksburg. Hi, David. Thank you. How you doing? I'm pretty terrific. I hope you're well. Yes, my questions about even talking about the last couple weeks. I haven't seen the analysts have a price tag for the year. Zero analysts zero and no research whatsoever. Zero. I checked Friday, Friday afternoon. Come up yet The answer is no. And I think that could be a future catalyst. For or which, if you're in Pennsylvania, Okay, now, now, as analyst start writing on this I mean, they love their right about new cos This is the fourth largest snack food company in the country. Last year to get over a billion dollars in sales. Only operating pretty much in the northeast in the middle attic. Imagine if they spread this throughout the country. It sounds and I picked up some chairs a couple about a week ago, and I'm pretty excited about it. I was just really surprised that nobody is covering it, you know, and nobody has a price target for it. It just takes some time was not strange to think. Take some time to develop the research, and then you've got to go through the compliance or illegal meat grinder. To get the imprint and distributed from your company. Do you have a personal price for the year? What do you think it's going to be? By the end of the year? I hate to say that what we've done is we bought CCH to convert into a and it's already up over 20% in many rare client accounts, I sold him to make a 20% gain in a week. We're gonna take some chips off the table, and that's what we did look great on Friday, moving up in a terribly down market, and so what we're doing is we're holding the stock or at least a 50% of the remaining position. Looking for a double from where we bought it, So I think it goes substantially higher. Thank you so much. You're welcome. David 92 6 extending their number 4 10 92 6. We'll be right back..

Charles David Finksburg Upjohn Ellicott City apple Pennsylvania analyst CCH John advisor
"biotech company" Discussed on WBZ NewsRadio 1030

WBZ NewsRadio 1030

02:19 min | 1 year ago

"biotech company" Discussed on WBZ NewsRadio 1030

"A vaccine is on at the Cambridge based biotech company more dental therapeutics zarrell taxes the chief medical officer for Montana he says they were prepared for an outbreak like this we have been working hand in hand with the NIH national institutes of health to understand how to leverage this platform to design antigen antigen that that piece of the protein of the virus that your music you can recognize so that we are ready in partnership with the right government bodies to react should that occur and and I think that's why we work in such a prime position to to move quickly I feel really privileged that we've been chosen by both the National Institute of health and the coalition of epidemic prepared innovations happy to collaborate with them on on the moving that tracking forward into clinical testing team other scientists working feverishly at their lab in Norwood so far there have been two documented cases of core coronavirus in the US group comprised of local police chief says it's time to give the legal immigrants driver's licenses in Massachusetts this is the M. M. C. C. or the Massachusetts city chiefs of police association and they voted to endorse the work and family mobility act and we find out what that is from Chelsea police chief prying ties it allows undocumented individuals which essentially is individuals in this country that are not lawfully present it allows these particular individuals to get a driver's license concern for us was that we seen many many people there are a lot of a driving now anyway meaning the driving the kids to school the driving to work so we want in terms of enhancing public safety roadways we want you to know individuals to be trained in the rules of the road and earlier today immigrants rights groups rallied outside of the state house in support of a bill that would bank Massachusetts a sanctuary stay advocates of the legislation say it will protect immigrants basic rights what in police custody can prevent police from becoming an accomplice to the trump administration's overzealous deportation of illegal immigrants Amy grunter was with the immigrants and refugee advocate coalition and when immigrants C. police courts involved in deportations they stop reporting crimes they don't seek help in an emergency they may not even go to the hospital because they're afraid that somehow.

Cambridge medical officer Montana Norwood Massachusetts M. M. C. C. Amy grunter NIH US Massachusetts city chiefs of p Chelsea
"biotech company" Discussed on 106.1 FM WTKK

106.1 FM WTKK

02:21 min | 1 year ago

"biotech company" Discussed on 106.1 FM WTKK

"Pennsylvania Avenue the president reached about treason at the other the March toward impeachment preceded Democrats have subpoenaed Rudy guiliani the president's personal lawyer who is at the heart of trump's efforts to get Ukraine to investigate political rival Joe Biden's family Giuliani spoke last night with fox I mean it is outrageous the only really sad part of this is how much in the tank and how corrupt this media has become they have corruption staring them in the face and they closed their eyes to it and then they make up charges against president trump one of trump's staunchest defenders Senate Majority Leader Mitch McConnell told C. N. B. C. he would have to consider articles of impeachment if the house approves them yeah it's a it's a Senate rule related to impeachment it would take sixty seven votes to try and so I would have no choice but to take it up Democrats moved aggressively against Giuliani requesting by October fifteenth text messages phone records and other communications that they referred to as possible evidence meanwhile the circle of officials with the knowledge of trump's phone call to Ukraine's president widened with the revelation that secretary of state Mike Pompeii a listened in on the July twenty fifth conversation congressman Christopher Collins of New York has resigned ahead of his expected guilty plea to charges related to an insider trading case involving his son and an Australian biotech company it wasn't immediately clear exactly what charges Collins would plead guilty to today in September the Republican representative from western New York pleaded not guilty to a revised set of. insider trading charges well folks in Montana dig out from an historic snowstorm people in the south wonder how much longer this endless summer can last more than a dozen daily heat records could fall each day through Thursday temperatures are well into the nineties in cities including Atlanta Knoxville and Tallahassee and now we have smart jackets Levi's says jacquard by Google technology will be built into some of its denim jackets to connect the clothing to the wearer's smartphone the tag about the size of a stick of gum talks into the jacket sleeve and connects to your device wirelessly via Bluetooth where stay connected with hand gestures like swiping touching and tapping the jacket cough wow. that sounds or appears in my mind to be a a third base coach. calling signals on..

representative Google Tallahassee Atlanta Senate Rudy guiliani Levi Knoxville Montana president New York Christopher Collins congressman Mike Pompeii C. N. B. C.
"biotech company" Discussed on KOA 850 AM

KOA 850 AM

01:38 min | 1 year ago

"biotech company" Discussed on KOA 850 AM

"It's a it's a Senate rule related to impeachment it would take sixty seven votes to try and so I would have no choice but to take it up Democrats moved aggressively against Giuliani requesting by October fifteenth text messages phone records and other communications that they referred to as possible evidence meanwhile the circle of officials with the knowledge of trump's phone call to Ukraine's president widened with the revelation that secretary of state Mike Pompeii listened in on the July twenty fifth conversation congressman Christopher Collins of New York has resigned ahead of his expected guilty plea to charges related to an insider trading case involving his son and an Australian biotech company it wasn't immediately clear exactly what charges Collins would plead guilty to today in September the Republican representative from western New York pleaded not guilty to a revised set of. insider trading charges well folks in Montana dig out from an historic snowstorm people in the south wonder how much longer this endless summer can last more than a dozen daily heat records could fall each day through Thursday temperatures are well into the nineties in cities including Atlanta Knoxville and Tallahassee and now we have smart jackets Levi's says jacquard by Google technology will be built into some of its denim jackets to connect the clothing to the wearer's smartphone the tag about the size of a stick of gum talks into the jacket sleeve and connects to your device wirelessly via Bluetooth where stay connected with hand gestures like swiping touching and tapping the jacket cough well that sounds or appears in my mind to be a a third base coach. calling signals.

Knoxville Google Tallahassee Atlanta president Senate Levi Giuliani Montana representative New York Christopher Collins congressman Mike Pompeii Ukraine trump twenty fifth
"biotech company" Discussed on KCRW

KCRW

03:25 min | 2 years ago

"biotech company" Discussed on KCRW

"Biotech companies are using tools to tweak the genes of common food crops. They call it, gene editing, and there's a lot of confusion about exactly how much government oversight. These crops will get NPR's. Dan, Charles has the story the company Kayla cst in Minnesota wanted to make a new kind of soybean where the oil is a little healthier more like olive oil, some wild relatives of soybean already have oil like this because a few of their genes are slightly different with particular mutations manage Sahu, the company's chief commercial officer says that led to a question can we have the same mutations in the modern varieties, which are grown by our farmers. The company deployed new technology similar to famous gene editing technique called crisper song calls it a genetic scissors which can go in and cut the soybean plants DNA, very precisely. And then comes out, and there is no foreign material or foreign genes in the soyabean. This is really important because if you insert new genes into a soybean, maybe you copied them from another kind of plant or bacteria. That's considered a genetically modified organism GMO you need government approval to sell a new GM can take years millions of dollars. But if you just take a little slice out of Jeep if you edit and don't add anything, that's a gray area. The European Union's decided that's still a GMO. The US though, says it's not and you don't necessarily need to get explicit government approval to sell that product Kilic's did ask for proof from the US department of agriculture and the food and Drug administration and got it we pink these important do Bill consumer trust signed also fifty which is critical to go through that oversight process on the other hand, there's a gene editing company in San Diego called Ciba's that selling. A new kind of canola seed and Ciba's never asked the USDA or the FDA to formally approve it now Ciba's actually used an older technology to create its canola. It induced lots of random you -tations in canola plas- by multiplying them in the lab and Petri dishes. Then it found exactly the mutation at wanted companies have been doing this for decades and never had to get government approval. So see didn't need to in this case either. And the company's executives say they also wouldn't have to if they did this with the newer, gene editing tools. Greg Jaffe, director of the biotechnology project at the center for science and the public interest says it's a troubling precedent. I don't think CBS's violating any law. But I think points out the fact that this is a voluntary process, and that in the future companies may or may not go through that process for a lot of consumers. That's not going to be acceptable. He says, gene editing is new it's powerful and people will have a lot of questions about it. Including is my food genetically edited the first step in having a discussion about technology is. Knowing what's out there. So Jaffe says let's at least have an official comprehensive list of every gene edited crop that farmers are harvesting and selling I think there should be a registry of these products IRA cultural crops that are going to go on the market. That have been g added I reached out several biotech companies to see what they thought of Jaffe Xijiang. They were noncommittal several of them said they want some kind of government oversight of this technology. They know that's essential for public acceptance. But the companies also trying to avoid anything that suggests to consumers that gene edited food somehow different from every other food,.

Greg Jaffe Ciba Jaffe Xijiang USDA FDA US European Union NPR Minnesota San Diego chief commercial officer Kayla GM CBS Dan Charles Kilic director
"biotech company" Discussed on Invest Like the Best

Invest Like the Best

01:52 min | 2 years ago

"biotech company" Discussed on Invest Like the Best

"It's like, no there's not one right way to do. This maybe talk through the process of stem. Centrex wasn't familiar with the business? Until this morning. I'm just doing some preparatory reading for this conversation seems like a fascinating business. So I would love to hear the story of you seeing it kinda through the relodge outcome realizing that there's some survivors pies. You're right. It's a huge outcome or the ones who tend to be able to Google and read about but nonetheless, I would love to hear how it went through your process. Well, the ones that aren't he comes don't actually aren't that relevant to venture capital. Because again, it's not about the downside ones. It's about the winners. And so I met again through network, I met the founder of stem Centrex one day for coffee. I'd seen a bunch of people know that we're interested in anything. So we're not just into tax. Oh, totally open to investing in biotech companies. Unlike a lot of firms so somebody from my network was like, here's an interesting one. So I met the founder for coffee not expecting much at all just because most founders and biotech are not necessarily what I'm looking for in a founder this blew that away in spades. In fact, the day that I met Brian Slinger Lind for coffee on our. I mean. I was so blown away that night happened to be the holiday party at Peter Teal's house. It also happened to be his one year anniversary with his wife, but I'm like while we have to get going on this. And we don't have anything such as we don't have any such thing as a Monday morning partner. Meaning so we just kind of say organic just meet us. Let's go from there. So I was like, hey, do you want to come to the holiday party tonight? Because a lot of us are going to be there and Aline easy way of doing this. So he has of course, check with his wife. One year anniversary, right? I don't think I don't know if my wife would have been through held, but she said, yes. And he came and that started that process if everybody realizing just how special Brian Scott and Dan were for stem Centrex in a way, we never seen in a biotech company..

founder Brian Slinger Lind Brian Scott Google Peter Teal Aline partner Dan One year one year one day
"biotech company" Discussed on Science Friday

Science Friday

01:36 min | 2 years ago

"biotech company" Discussed on Science Friday

"Payments from drugmakers or relationships with biotech companies anything that could consciously or unconsciously buys your findings anything that people reading should really know about. But over the past few months investigations by propublica in the New York Times have shown that the honor system has major cracks in it journals are asking, but a lot of time doctors aren't telling Katie Thomas as a reporter at the New York Times who co-authored one of these recent investigations, and she's here to tell us what she found, Katie Thomas. Welcome to science Friday. Thanks for joining us. Thanks for having me. And if you're a medical professional, we'd like to hear from you. How do you approach conflicts of interest can give us a call to ask your questions or give us your thoughts at eight four four seven two four eight two five five that's eight four four si- talk or you can tweet us at scifi? First of all, this is amazing reporting, Katie, and maybe can start by telling us how this investigation I came about. Sure, it started us several months before I story when my colleague Charles Ornstein at propublica just got a tip from from a reader who had who had pointed us to the the chief medical officer. At the time at Memorial Sloan Kettering cancer center, stamos, Dr Jose Basell, and he's a leading cancer researcher, very very well known in the field. And this this raider just pointed us to the fact that in many of his journal articles and conference presentations and other public appearances, he wasn't reporting any disclosures, even though you know, if you if you dig around even just a little bit on the internet, you can see that he had multiple relationships with a lot of different companies..

Katie Thomas New York Times Memorial Sloan Kettering cance Dr Jose Basell propublica Charles Ornstein reporter medical officer stamos
"biotech company" Discussed on Biz Talk Radio

Biz Talk Radio

07:52 min | 2 years ago

"biotech company" Discussed on Biz Talk Radio

"When a brand new company. That's just just listed. Been a long time. But I have been following this company since a friend of mine was involved in some trials over in Finland. And we talked about it. This goes back a couple of years. I think there may be some great opportunity here. It's a very aggressive position. But if you're young and you've got some time, I feel pretty good. This is a start up biotech company that pretty amazing the the money that they're starting out with so. I'm going to talk about it. If I'm going to do it if I'm gonna put it on my list, you're going to hear about it on the conference call I you might might not even get on my list that day, but it all. I'll let you know it's coming. And if you want to get ahead of it. You can do it. Eight four four seven zero seven fifty five thirty three. Let me go to Mike Mike is calling us from Texas. Hey, Mike, how you doing, Dan? I'm good. Thank you, brother. You a question about a a variable annuity that I'll and I've had it for. And. I was considering that get some money out of it and finding a Ralph our right because I don't have a raw. I don't know if I'm through late in the ball game through that. I'm sixty three years old still work. I'll probably gonna work Stephen, dear. My never quit. I don't know. But. Network. I think it's I think it's a great idea. I would do it. Now. I don't want you to have any penalty. But you should be able to take at least ten percent out without any penalty. Even if you do still have surrender charges. I don't know how many years you've had it. Twenty how many? Okay. Yeah. I would definitely do it. I would as a matter of fact, I would I would look to take sixty five hundred out. And I would do it. Now. The sooner the better. And I would that that would fully fund a Roth IRA, I traditionally Mike am not for funding the IRA at one time one lump sum because you miss out on dollar cost averaging in when things get bad, and I don't like to miss out on that maybe a bad month or a couple of months, but since things are kind of starting out right now at Lowe's and good valuations. I think it'd be a great icy that idea to do it sooner sooner soon as you can't cannot still bond far two thousand eighteen. Yes. Ross you sat right. You need to call. When you set that Roth up wherever you're setting it up. I would ask them that question. I don't know whether that rule was changed or not. But I think you can I'm reasonably certain that you can ninety eight percent sure that you can. So you could theoretically put thirteen thousand in and designate sixty five hundred to two thousand and eight good point. And yes. On your opinion. I know you don't like tonight but thank about that annuities with. Yeah. So I mean, I think as a company. Yeah. As a company, I don't have anything against vanguard. I think they're one of the best as a Biblically responsible mutual funds. Forget about it. So if you were if you wanna diversify and be responsible if you want to just be conservative get a little bit of a gain. You know, they have I have a couple of their funds on my list. Like, they're like there are flation protected bond fund a couple of other government bond funds that would be Biblically responsible. But as far as growth goes, you're not going to be able to get anything there that is going to be Biblically responsible. So obviously, I would say, no, I'm not saying those funds in and of themselves or the company is bad. But it is what it is. You know? So I can't I can't get too excited about it. You get that already. Dan. I really appreciate your time. You're on your phone app. All the time. That's the. Great. Thank you. Great. With mike. Thank you. All right. Thank you so much, Mike. I appreciate that. And I'm glad Mike mentioned the phone acquis and talked about it today. But there's somebody else. It's listening to on the phone. You know, it's a great place. Listen, you can even make a call there. Mike did that but you can go to connect the connect button. And you can say, you know, ask your question. All dial up the phone number the call in number four years and get in the queue. But anyway, it is then you don't need to be listening because you're listening while you're on hold. And then you when you get off it'll pick back up, and you're here. So man that is a great place to listen, just just always remember, folks, really important, and the more and more people that we have that listen on a phone out. We get this question. There's a little bit of a delay. So when you start out in the morning, and you go to the phone, and you say, okay dance coming on tonight. Oh, five so you go, and you listen, you say, oh, my word they're playing I think it's yesterday shower they're playing something else. Just be patient. It's catching up. There's a there's a delay. So don't you don't have to call right? Oh, you know, they're playing yesterday's show. No, we're not. That's what you're hearing. Because there's a little delay. If you give it a minute. Know, you're you're here the star of the show. So just keep that in mind. Anyway, great stuff, and you go to any app store. Doesn't matter. What kind of phone? You have go to the app store financial issues. There's the right there too. Great app. I hope you'll do that. Let me go to Jordan Jordan's. Do. We have time Jordan. I'm gonna have to hang hold you over brother. I'm sorry. If I go now, I'm going to have to go very, very quick. So. Hang in there. We've got a line open eight four four seven zero seven fifty five thirty three eight four four seven seven fifty five thirty three. If you've got a question Jewett it up right now, the NASDAQ and the s&p turned negative this right now. So again, we'll see how it goes. You know, this is amazing. Here's the headline small business sentiment to declines to our fourteen month for the low. Unbelievable. Yeah. And fourteen months ago, we were all time record high that was last reached or actually above when it was last reached in nineteen eighty three we are at an all time high for where we've been for the last fifteen years or they left that part out. Yes, they did. This is mainstream media where I was just talking about earlier in this hour. We have this unbelievable force of mainstream media disseminating, nothing, but negativity try to have a self for filling prophecy that things really are negative.

Mike Mike Finland Dan Stephen Jordan Jordan Ralph Texas Ross Lowe Jewett ninety eight percent sixty three years fourteen months fourteen month fifteen years ten percent
"biotech company" Discussed on Newsradio 970 WFLA

Newsradio 970 WFLA

01:54 min | 3 years ago

"biotech company" Discussed on Newsradio 970 WFLA

"Ninety five, congressman Chris Collins, vows to fight charges of insider trading the New York Republican pleaded not guilty to charges related, to an Australian biotech company in a statement Collins insisted the charges are meritless hill, mount a vigorous, defence Collins stated that Won't comment further, meanwhile prosecutors say that he made a phone call to friends and family telling them to sell stock in the biotech company before a failed test led to the Stompie's company's stock collapsing President Trump's legal teams responding to special counsel Robert Muller regarding his. Request for in one on one interview with the. President a statement from the council to president j Secolo says counter proposal has been made but, he won't disclose, the content. Of that, letter Trump's other lawyer, Rudy, Giuliani has, expressed reluctance, towards a meeting, and he has hinted that he believes it may maybe a perjury trap, for, the, president, fewer, Americans seeking out first time unemployment benefits. The Labor Department reports today the number of initial, jobless claims fell, by six, thousand last week to two hundred thirteen thousand analysts had. Been expecting that, number to come in right around two, hundred seventeen thousand it's nine thirty two The Tampa Bay forecast. From, news channel eight meteorologist Lee span partly cloudy thirty percent chance of afternoon showers and storms high ninety two right now mostly sunny eighty three degrees at your severe weather station NewsRadio nine. Seventy WFL a next update at ten on Chris SRP invoice list price dealer price tilbern up here if your car, shopping you've probably heard these terms but what do they, mean it's so confusing well, it was confusing not anymore we tell you about. True price from, truecar it's a price that actually means something because it's the exact price you'll pay for the car you want including fees and accessories, and best of all you'll know, if you're true prices competitive because truecar. Shows you what other people are paying for the same car that you want so..

president Chris Collins Robert Muller Trump Giuliani congressman New York special counsel Stompie Labor Department perjury Lee j Secolo Rudy The Tampa Bay eighty three degrees thirty percent
"biotech company" Discussed on 600 WREC

600 WREC

01:46 min | 3 years ago

"biotech company" Discussed on 600 WREC

"And John Rick gates is now off the at Paul manafort's financial crimes trial in Virginia hit with more questions about embezzlement and marital infidelity gates testified that he and the president's former. Campaign manager together hid money from the IRS overseas and submitted fake Mortgage and tax documents the New York congressman. Chris Collins his son and. His fiancee's father phase insider trading charges cons is a Republican served on the board of an Australian biotech company. Congressman Collins violated his duty. To keep Nate's information secret the company's called innate immunotherapy critics. Limited US attorney Jeffrey Berman says Collins tipped off the other defendants that trials for an MS drug had failed so they'd, sell their stock in the company before it crashed congressman Collins denies. Doing, anything wrong they're still ballots to, count but Kansas secretary, of state Chris Kovacs says he'll start campaigning as if he won the Republican primary for governor is. Imperative that we begin running understanding that this is a tentative victory President Trump had, endorsed him over. The current governor Jeff Collier co back at last count was two hundred votes, ahead with eight to ten thousand provisional traffic coming from the wolf chase Toyota studio wolf chase Toyota once again Memphis is number one volume store afternoon as we Wind down your lunch hour we've had a relatively quiet day for you right now everything is, continuing to, move, pretty, smoothly. Along interstates, from no major crashes traffic trouble spots you're bored Again just, be a little bit of poplar. Near to forty. South along the border between, two forty Riverdale where they've. Been repaving in that area it's a little tricky to, travel in some spots many Hayes. With your total traffic he's a. Box thirteen weather update and FOX thirteen meteorologist Elizabeth de Maureen, we'll see mostly cloudy skies with. Scattered showers? And storms right through the afternoon and. Evening take it easy,.

Congressman Collins congressman John Rick gates president Toyota Paul manafort Chris Kovacs embezzlement financial crimes Virginia New York IRS Nate Trump Jeff Collier Kansas Jeffrey Berman US attorney Riverdale
"biotech company" Discussed on WIBC 93.1FM

WIBC 93.1FM

09:45 min | 3 years ago

"biotech company" Discussed on WIBC 93.1FM

"This isn't some at least. From the first blush Pie in the sky it's it's it's it's nothing This is. This is some big stuff right here insider trading. Here's how, it goes down The the congressman Has a relationship with an Australian biotech company, called innate immunotherapy He is a board member On. On this on this company Right in June of twenty seventeen so we're talking about a year. Ago in June of twenty seventeen he passed information about drug trials to his son This is the indictment alleges was to help him quote make. Timely trades in the company stock anti tip others Yeah that, that's the definition of insider trading that's what it is and it's the. Stuff that people. Hate this isn't the. We're not talking about one party versus another party here, don't get ridiculous don't get crazy this is the. Stuff That people can't stand And I assume he's going to. Suffer greatly for now all of this. Is just coming out the story broke in the. Last hour or so they're going to be having a press conference about it later according to the to the indictment they avoided over seven hundred sixty eight thousand dollars in losses that they would have otherwise incurred had they sold their stock after the, information was made public So you know This. Is going on it's a, hit now now is it going to be a hit to, Trump, because every oh that's the only question in politics is going to be hit. The Trump now Why why because. The guy wants endorsed President Trump. That's that's that's absolutely. Meaningless absolutely meaningless but I, I will tell you that it's just this is the kind, of, stuff that people hate and they should hate they should be bothered by it I'll let the investigation go on of. Course, representing Collins saying that. There's going. To be, a defense a vigorous defense according to his lawyers to clear his good name I have not heard anything yet. About resignation or anything alike it He is going to surrender to federal agents this morning. They'll appear in federal court in, lower Manhattan, today there will be this press conference they'll detail all, the charges so we're going to follow that story but one of. The big stories of today is what happened in these special. Elections Because all, we hear about all we hear about is the Blue. Wave that's coming this giant massive, Blue Wave that's. Going to wash over us like a blue glove the. TSA it's gonna feel are undersides and it's gonna. Creep its way into our reverses. Graphic but fact don't don't. Tell me the I despise the TSA. In a way that is irrational but I keep hearing about this this Blue Wave That were clearly. Lost in that in Ohio there's. A special election That was going. To be the the bellwether that was the, big story in Ohio we were going to see what happens now the Ohio a special election is. Happening because the congressman that was there decided to take another job his name. Is packed to berry He decided to take a job Okay he left the. House in January resigned in January so they had to, have a special election in August and then they'll. Have another election, with the. Midterms it's very, strange very Zhang's they've the. Law whatever the case may be. They don't wait till the, midterms so you had the Republican he's. A state Senator named Troy bothersome you. Have a democrat named Danny O'Connor this district that Trump won by eleven points is the district. That's been, Republican since the, eighties John casick the current governor. The anti Trump never Trump governor, father was a mailman he his that's where. He was a member of congress that's where. He was a member of, congress so it's this long Republican stronghold Democrats saw an opportunity and for a long while there for a long while they're, the democrat. O'Connor was doing very very well Republicans. Poured crazy money into this race Because O'Connor outraged baldur's then by. Like two. And a half. Million dollars like four hundred fifty. Thousand dollars the outside money was four million bucks. And. Then bring on President Trump no sweat out on. A tweet this morning or is it last night when, I decided to go to a high of tribe. Alderson he was, down in. Early voting sixty, four to thirty six that. Was not good I love the. Way he man's flame that, for me I feel better I feel. Better about that but after my speech. On Saturday night there was a big turn for the better now try wins a great victory. During a, very tough time, of the year for voting he. Will win big in November the, results which are all in but they may. Be questioned because there's some absentee votes in. Some provisional votes tribe Alderson, the Republican one hundred one thousand five hundred seventy four votes Danny O'Connor the democrat ninety nine thousand eight hundred and twenty, that is. A difference of one thousand seven hundred And fifty four. Votes now I just said that. This was a district that Trump won by eleven There is. A lot to take away from this race and and I want, to, employ, people to take this. I, want you guys to disagree with me if you want Twitter Tony cats Number one I want to put. An end to the Blue Wave concept I don't see it I know people talk about it I agree that. Republicans are not having easy of a time as as maybe they, should, be But Blue. Wave I don't see it I. Gather there won't be maybe losses in in. The house but Blue Wave massive destruction I don't I absolutely don't see it and. I, think that this race, is very proof positive of it, here's what I take from it first Republicans should not rest on their laurels think about how much money it took in what. It took to get this district now this one's by itself and when you have a midterm. You've got a lot more cover, is why Democrats are so keyed in on this race because they thought this was their moments they know that they probably. Won't win, in a term and more people are used to voting that's. When you vote special. Elections not many as many people. Come out and they could focus all their energy and all their media assets on one race So they're focusing everything and you take a look at. The brutality of the month the, President Trump hat right I want you to keep that in your head but I am going to focus on the Republicans They had. To dump crazy money into this race this was. A race that Trump. Won by eleven points and they're squeaking out by less than, two thousand votes it's, gonna? Be tough and you better be on a game, people who need the dollars better have the dollars You need to being misses a cultural war as everything is and and from the. Outside looking in you, gotta be looking at it as a. Cultural war Republicans do not have an easy route Two to victory in the midterms we're going to be talking to just after the break with Andrew, Malcolm McClatchy news service because he has a path for Republicans we're going to dig into that Republicans have to work hard this did not come. Easy because Trump hate is real and it can take away an eleven point margin that's how strong it is you know what it isn't strong enough to win you, think of the horrible month I, just said the horrible that that Trump has had Helsinki and and, some of the other comments and LeBron stuff and everything else. In the LeBron stuff in Ohio And the Republicans. Still wins the? Trump only goes so far it. Will do damage but you still. Have to have a message and here's a guy who had all the money in all the all this going for him in Daniel Connor and couldn't pull it out It's gonna be a tight election it's one of the big takeaways from Ohio that the Blue Wave is not real however in order to ensure that you actually have to work at it that's that's the point and Republicans sometimes they. Are sit back I they don't own the aggressiveness that. That Democrats own and that is to tetris they have to own it. And they have to toughen up. In all these races, and run hard because Democrats are desperate to, make this a referendum about President Trump they believe that Trump eight and jenning up Trump trumpet we'll get enough people out to the polls And they're pretty. Close the pretty, closeness Ohio district twelve just not close enough Andrew Malcolm McClatchy. News service is, up next what are the keys to, make sure the GOP wins what. Does he think President Trump's issue. Is or is President Trump not even the issue that's coming up I'm Tony hey..

President Trump Trump Danny O'Connor President Ohio congressman TSA Alderson Manhattan Daniel Connor Andrew Malcolm McClatchy congress Twitter Collins Zhang John casick Senator GOP LeBron Tony
"biotech company" Discussed on WCBM 680 AM

WCBM 680 AM

01:48 min | 3 years ago

"biotech company" Discussed on WCBM 680 AM

"Two six six eighty four ten ninety two six hundred. Eighty let me give you folks an idea and I rarely say, this but I want you to write this down because this is something I think will fit a lot of people's. Portfolios There's an investment. It's what's called a closed and mutual fund it's a mutual fund, portfolio but it trades on the stock exchange so you it by individual shares of AT and t. your IBM okay And in it is all the. Top healthcare stocks this is, called Tekla t k LA Tekla healthcare. Opportunities to symbol is t h q I repeat that t h. Hugh The top Canada portfolio Johnson and Johnson is number one. Followed by United health group Gilead sciences, two major biotech company Pfizer Abbott labs Merck, Amgen Medtronic Abby and cell gene and other by check the ran at the top ten. So when you buy into this. Portfolio you you basically by the, top healthcare companies which is a group that's been pushed down, a little bit for a number of reasons healthcare is here to stay folks you can't get away from healthcare and we think along with. A lot of other outside experts it's an opinion that this sector can move fifteen to. Twenty percent the next twelve months But here's to beautiful things about investing this way Number one All these closed end funds every day at, market close we calculate a net. Asset value all, that is is we hypothetically? Liquidate stocks and if we paid off all, the shareholders what would? You, get well the net asset value of Tekla healthcare.

Tekla healthcare Johnson AT Gilead sciences Pfizer Abbott Medtronic Hugh Amgen IBM Merck Twenty percent twelve months
"biotech company" Discussed on Absolute Advantage

Absolute Advantage

04:22 min | 3 years ago

"biotech company" Discussed on Absolute Advantage

"That then we have to establish a purpose and oftentimes some places we can do it depart mentally but in many places i think you've done some work with engineers yes yes yes yes just think of the different engineers that are involved in a process to produce a product they each have their own purpose and we have to make sure that we have very clearly spelled out not just what use the same names fred's purposes but sues purpose as well because they're interrelated and we have to make sure people understand how this purpose idea fits so that we can do what we set out to do i love that so it's not just the purpose of the company and the purpose but it's the purpose of eaten each individual what their purposes as it connects relates to the work that that is being done at the company and who they serve and that sort of thing is that correct there are some companies that do this very well and there are some companies that could have some hell totally okay we got through that without saying okay so these companies that do it well what is what do they do well they they're not trying to tell people okay here's a mop and here's a bucket go clean that toilet no they're helping people understand the reason we've asked you to do this because the people on board of our company this is what we're trying to do i'm gonna go back to that book that i related to earlier that tribal leadership book because they put in there a really good case study of the different levels of leadership and the fifth level is really transcends so much of humanity and if we could get people to that level home i gosh it's amazing the changes that we could make and i'm going to use a company that they use in there and it's a mostly wouldn't understand is a biotech company called amgen and when you ask amgen employees what they do now i haven't done this in in the near term but in the recent past those employees would not give you their job description they would not give you their job title they would not tell you what department they worked in with they would tell you is work hearing cancer well that's a purpose yet and they all believe that that is part of their purpose so if you are the ceo of the company if you're the biomedical engineers in the biomedical chemists whatever you are whoever you are if you're at the other rungs of the ladder you're the people that are taking care of what we used to call the mail room and doing all that administrative kind of stuff wherever you are in the organization a big partier purpose is to help us cure cancer people can get on board with that you bet absolutely so i think at this this purpose thing does go with a company made the company if a company gets that level five they can have a universal purpose that people can buy into regardless of what they do but for tribal level four companies they're probably better off doing it from that individual perspective insane okay fred so this is your purpose this is what we need you to do to help us do what it is that we're doing overall love that too curious staying on this topic for for just a moment do you have any tips for our listeners as it relates to hiring and for you know specifically we're talking run the idea of purpose and you're building you're in that process of building teams how does this integrate into your process when you're when you're looking to hire for these teams if i can i'm gonna this two pieces because the first piece is absolutely critical you talked about this hiring process but the other piece that if just because you have a good hiring process means nothing if you don't have good on boarding process yes amen to that thank you so step two in the model is outfitting the plane so that you can get where you wanna go and so you have to look for people that.

"biotech company" Discussed on GeekWire - Geared Up

GeekWire - Geared Up

02:02 min | 3 years ago

"biotech company" Discussed on GeekWire - Geared Up

"In a lotta biotech companies are doing that to research on immune disorders the benarrivo research institute a focuses almost exclusively on that so there's a lot of that research going on right now in seattle and a lot of people depend on the technology that adaptive makes to have the data to do that interesting it's funny because we just had a conversation recently with pseudogovernment hohmann the ceo of the gates foundation who was talking about immunotherapy this whole idea that you would reprogram your immune system the thing that usually fights the common cold to go after cancer and she was saying will he may be they could figure out how to use the immune system to go after other diseases so in here we have it is that my following the right thread as a little differently of a little different so what this would do is screen four disease is to find them on immunotherapy would actually god and attack the cancer cells and and kill them and there's a lot of companies including ones in seattle genoa therapeutics her a success lee doing that this is more like think of your immune system and all the little parts that make it up like a book and actually had the pleasure of of speaking to peter lee the vp of a in research at at microsoft whose involved in this on the machine learning and we're gonna have a podcast featuring him next week actually so keep an eye on your feed for that but he described what's happening as the immune system is a book and in the book there are lots of different words the words might be uh that's a t tcell or a different kind of antigen that you have and they need to be able to translate those words into a diagnosis and that's where machine learning comes in the machine learning is able to can read all the words and spit out this person has multiple sclerosis or this person has x y z that's what all these words are telling me so it's more of a detection tool but on the other hand it's a really interesting artificial intelligence kind of challenge to to put all this data together in a way that's actionable.

benarrivo research institute seattle ceo gates foundation immune system cancer vp genoa peter lee microsoft artificial intelligence
"biotech company" Discussed on Bloomberg Radio New York

Bloomberg Radio New York

01:56 min | 3 years ago

"biotech company" Discussed on Bloomberg Radio New York

"Move forward but how does working with china and any kind of regulations around genetically modified crops as that change the way you do business at all i think china historically has been a concern bob global biotech companies around getting approvals in china and there wasn't a a clear process i think that's improving i think they're the acquisition of of syngenta further gives incentive for china to enhance the improve the regulatory the approval process since we were acquired seven months ago gene been six biotech traits approved by china before that there weren't any approved for quite a while and those are at one of our traits but five from other global biotech companies like monsanto dupont uh bear um and others so i think it's a it's a positive and i think it's very important you have made it an investment i think it's about four hundred million dollars in the 2 seed business recently in the us un eu indian i n k yes it division and thirty one new corn hybrids 21 new soy bean varieties tough how does that a test system work because you spending four hundred million you obviously have a plan of how to spend where does that money go it goes into interbreeding the products and to putting the traits into the biotechnology traits into the products and and and more feet on the ground calling on farmers to two to create the demand for our products in more prompt more people calling on the distribution and retail channel to support our product sales so it's a it's an investment in us agriculture the united states farmer is the most advanced in the world has the.

china genetically modified crops monsanto dupont us four hundred million dollars seven months
"biotech company" Discussed on Bloomberg Radio New York

Bloomberg Radio New York

01:54 min | 4 years ago

"biotech company" Discussed on Bloomberg Radio New York

"Then proceed to the the biotech companies very thoughtful explanations are right now let's go to our 991 newsroom in washington dc we've got nancy lyons world and national headlines thanks tom senators continue to work on healthcare with a vote on a skinny the repeal of obamacare expected either today or tomorrow that measure would eliminate just a few pieces of the current health care law like insurance mandates and taxes on medical devices white house members are leading in a fiveweek recess tomorrow and there's a place to have a tax reform proposal in their hands before they go bloomberg's bloomberg bna's as cast his buses says the hope is this new proposal would reveal more details than a white house document that was released earlier this year plan to cut it out about uh what progress had been made it we're working very hard on details of the plan and we look forward to anything them when we release them so we we don't really know what point we end the plan but it might be more detailed dan in the aid for all tax guidelines released by the trump administration gop leaders want to pass some sort of tax tail before the end of the year the ohio state theories back open today that the rides are gonna be shut down following a deadly accident yesterday one man is dead seven others were injured when it's real ride broke apart variety does really really doesn't circles sites yes so the the ride is tasked all of its inspections prior to that incident the four deciding how to handle residents from other countries post brags it the uk is ordering an assessment of the contributions european union citizens make to the british economy global news 24 hours a day powered by more than twenty seven hundred journalists than analysts in more than 120 countries there's an host.

bloomberg uk washington nancy lyons gop ohio shut down 24 hours fiveweek
"biotech company" Discussed on Bloomberg Radio New York

Bloomberg Radio New York

02:17 min | 4 years ago

"biotech company" Discussed on Bloomberg Radio New York

"Dan already very interesting plan to underway from students have gone to medical school where they end up may come as it benefits surprise with that story our own an mass do reporter at bloomberg news cohost of the bloomberg baystate business our from our bloomberg when a six one studio in boston and i am so a curious about this story could have here is and may tell us what's going on thanks so much carolyn curry well he as you know i do a lot of reporting on biotech companies in boston and i've been noticed thing in the last couple of years a lot of ceos especially young ceos who've gone straight from medical school into business they're starting healthcare companies they're running hedge funds their consult tang analyst cited to look into whether there is some data on this because i personally was surprised to be meeting more and more of these people because i assume that when i know somebody goes to medical school that person becomes a practising doctor and you know ever sense for you dr exactly and i didn't realize that is really becoming more and more common for people to say to hack with the hospital clinical life i wanna start a business or want to go into business it's it's interesting to in the world biotech here i mean that's you know as i have friends who are ceos about two companies and their many of them doctors themselves in the discus a better understanding of how the drugs themselves are gonna work yeah exactly and it's not that it's a bad thing and eating well just it depends on who you ask me because most people are going to healthcare they're finding ways to improve our healthcare system in some way and and then a lot of them are saying like practicing medicine isn't a great deal for doctors anymore it doesn't necessarily make you wealthy it promised a lot of freedom and for various reasons it's more appealing to cantamessa not that there is this doctor shortage in the united states can get the goahead noga guy quite that's a problem the fact that there are few durham enough doctors and and it as a virtual twenty percent of all over the age of sixty yes let and the baby boomers are going to make this a really big struggle i haven't niece ran his in is in medical school.

Dan reporter bloomberg boston hedge funds analyst healthcare system united states durham baby boomers bloomberg carolyn curry twenty percent